The effect of a low-protein diet in pregnancy on offspring renal calcium handling

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 2, 2007, Pages

  Ashton, Nick ^a   Al Wasil, Saleh H ^a   Bond, Helen ^b   Berry, Jacqueline L ^c   Denton, John ^d   Freemont, Anthony J ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bone; Kidney; Programming

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALBINDIN; CALCIUM; CALCIUM CHANNEL; HORMONE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; KIDNEY; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RAT; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; BONE AND BONES; CALCIUM; CALCIUM CHANNELS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DIET, PROTEIN-RESTRICTED; DIETARY PROTEINS; FEMALE; FETAL NUTRITION DISORDERS; GLOMERULAR FILTRATION RATE; HYPERCALCIURIA; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; MALE; NA(+)-K(+)-EXCHANGING ATPASE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; SODIUM-HYDROGEN ANTIPORTER; TRPV CATION CHANNELS;

EID: 34547641718     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00523.2006     Document Type: Article

References (47)

1. Ahmed MH, Ashton N, Balment RJ. The effect of chloroquine on renal function and vasopressin secretion: a nitric oxide-dependent effect. J Pharmacol Exp Ther 304: 156-161, 2003.
2. Armitage JA, Lakasing L, Taylor PD, Balachandran AA, Jensen RI, Dekou V, Ashton N, Nyengaard JR, Poston L. Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol 565: 171-184, 2005.
3. Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 301: 259-262, 1990.
4. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 2: 577-580, 1989.
5. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341: 339-341, 1993.
6. Berry JL, Martin J, Mawer EB. 25-Hydroxyvitamin D assay kits: speed at the expense of accuracy? In: Vitamin D Endocrine System: Structural, Biological Genetic and Clinical Aspects, edited by Norman A, Bouillon R, and Thomasset M. Riverside, CA: University of California, 2000, p. 797-800.
7. Bond H, Hamilton K, Balment RJ, Denton J, Freemont AJ, Garland HO, Glazier JD, Sibley CP. Diabetes in rat pregnancy alters renal calcium and magnesium reabsorption and bone formation in adult offspring. Diabetologia 48: 1393-1400, 2005.
8. Borke JL, Caride A, Verma AK, Penniston JT, Kumar R. Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol Renal Fluid Electrolyte Physiol 257: F842-F849, 1989.
9. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J, Slatopolsky E. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol Renal Fluid Electrolyte Physiol 270: F454-F460, 1996.
10. Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 13: 169-177, 2000.
11. Cooper C, Cawley M, Bhalla A, Egger P, Ring F, Morton L, Barker D. Childhood growth, physical activity, and peak bone mass in women. J Bone Miner Res 10: 940-947, 1995.
12. Cooper C, Fall C, Egger P, Hobbs R, Eastell R, Barker D. Growth in infancy and bone mass in later life. Ann Rheum Dis 56: 17-21, 1997.
13. Cooper C, Walker-Bone K, Arden N, Dennison E. Novel insights into the pathogenesis of osteoporosis: the role of intrauterine programming. Rheumatology (Oxford) 39: 1312-1315, 2000.
14. 2. Am J Physiol Renal Physiol 272: F781-F788, 1997.
15. Doucet A, Katz AI. High-affinity Ca-Mg-ATPase along the rabbit nephron. Am J Physiol Renal Fluid Electrolyte Physiol 242: F346-F352, 1982.
16. Ferrari S, Rizzoli R, Slosman D, Bonjour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 83: 358-361, 1998.
17. Freundlich M, Alonzo E, Bellorin-Font E, Weisinger JR. Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17: 1396-1401, 2002.
18. Friedman PA. Codependence of renal calcium and sodium transport. Annu Rev Physiol 60: 179-197, 1998.
19. Friedman PA. Mechanisms of renal calcium transport. Exp Nephrol 8: 343-350, 2000.
20. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C. Intrauterine programming of adult body composition. J Clin Endocrinol Metab 86: 267-272, 2001.
21. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, Minicuci N, Crepaldi G. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 149: 209-213, 2003.
22. Gluckman PD, Hanson MA. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15: 183-187, 2004.
23. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, Weaver C. Peak bone mass. Osteoporos Int 11: 985-1009, 2000.
24. 2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999.
25. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8: 277-289, 1994.
26. Langley-Evans SC, Gardner DS, Jackson AA. Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J Nutr 126: 1578-1585, 1996.
27. Langley SC, Jackson AA. Increased systolic pressure in adult rats induced by fetal exposure to maternal low protein diet. Clin Sci (Colch) 86: 217-222, 1994.
28. 2+ pumps (PMCAs) in pathologies of mammalian cells. Front Biosci 7: 53-84, 2002.
29. Lloyd T, Andon MB, Rollings N, Martel JK, Landis JR, Demers LM, Eggli DF, Kieselhorst K, Kulin HE. Calcium supplementation and bone mineral density in adolescent girls. JAMA 270: 841-844, 1993.
30. Magyar CE, Zhang Y, Holstein-Rathlou NH, McDonough AA. Proximal tubule Na transporter responses are the same during acute and chronic hypertension. Am J Physiol Renal Physiol 279: F358-F369, 2000.
31. Manning J, Beutler K, Knepper MA, Vehaskari VM. Upregulation of renal BSC1 and TSC in prenatally programmed hypertension. Am J Physiol Renal Physiol 283: F202-F206, 2002.
32. Matkovic V, Kostial K, Simonovic I, Buzina R, Brodarec A, Nordin BE. Bone status and fracture rates in two regions of Yugoslavia. Am J Clin Nutr 32: 540-549, 1979.
33. 3). Clin Chim Acta 190: 199-209, 1990.
34. Mehta G, Roach HI, Langley-Evans S, Taylor P, Reading I, Oreffo RO, Aihie-Sayer A, Clarke NM, Cooper C. Intrauterine exposure to a maternal low protein diet reduces adult bone mass and alters growth plate morphology in rats. Calcif Tissue Int 71: 493-498, 2002.
35. Oyhenart EE, Guimarey LM, Fucini MC, Quintero FA, Orden B. Effects of bilateral uterine vessel ligation on skeletal growth in rats. Clin Exp Obstet Gynecol 29: 121-125, 2002.
36. +-ATPase activity in thick ascending limb and of concentrating capacity. Am J Physiol Renal Fluid Electrolyte Physiol 249: F723-F728, 1985.
37. Sahajpal V, Ashton N. Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero. J Physiol 563: 193-201, 2005.
38. 1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet. Clin Sci (Lond) 104: 607-614, 2003.
39. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16: 2529-2542, 1997.
40. Schleiffer R. Parathyroid hormone and genetic hypertension. Int J Cardiol 35: 303-310, 1992.
41. Swolin-Eide D, Dahlgren J, Nilsson C, Albertsson Wikland K, Holmang A, Ohlsson C. Affected skeletal growth but normal bone mineralization in rat offspring after prenatal dexamethasone exposure. J Endocrinol 174: 411-418, 2002.
42. Sylvia VL, Del Toro F Jr, Hardin RR, Dean DD, Boyan BD, Schwartz Z. Characterization of PGE2 receptors (EP) and their role as mediators of 1α,25-(OH)2D3 effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 78: 261-274, 2001.
43. Vasarhelyi B, Dobos M, Reusz GS, Szabo A, Tulassay T. Normal kidney function and elevated natriuresis in young men born with low birth weight. Pediatr Nephrol 15: 96-100, 2000.
44. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49: 460-467, 2001.
45. Yarbrough DE, Barrett-Connor E, Morton DJ. Birth weight as a predictor of adult bone mass in postmenopausal women: the Rancho Bernardo Study. Osteoporos Int 11: 626-630, 2000.
46. Yingst DR, Massey KJ, Rossi NF, Mohanty MJ, Mattingly RR. Angiotensin II directly stimulates activity and alters the phosphorylation of Na-K-ATPase in rat proximal tubule with a rapid time course. Am J Physiol Renal Physiol 287: F713-F721, 2004.
47. Zhang YB, Magyar CE, Holstein-Rathlou NH, McDonough AA. The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na,K-ATPase and redistribution of apical NHE-3 during acute hypertension. J Am Soc Nephrol 9: 531-537, 1998.